The Valley Desk

ArticleLupus science & medicinePublished

Belimumab prevention against organ damage over 8 years and safety up to 13 years: three pooled open-label, long-term extension SLE studies

Read the publication ↗ Open access copy ↗

Regional connection

Verified An author affiliation on the Europe PMC record names GSK. Affiliation source

Institution
GSK

Publication record

Type
Article
Venue
Lupus science & medicine
Published
Subject terms
Humans; Lupus Erythematosus, Systemic; Immunosuppressive Agents; Glucocorticoids; Treatment Outcome; Drug Therapy, Combination; Adult; Middle Aged; Female; Male; Antibodies, Monoclonal, Humanized; Biological products
PubMed ID
42833728
PubMed Central ID
PMC13646960
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal